tiprankstipranks
Advertisement
Advertisement

HK:1244 Stock Latest News

3D Medicines Extends HK$50 Million Note to Puxin, Flags Disclosure Lapse
Company Announcements3D Medicines Extends HK$50 Million Note to Puxin, Flags Disclosure Lapse
8d ago
1244
3D Medicines Advances Oncology Platforms Despite Envafolimab Revenue Dip in 2025
PremiumCompany Announcements
3D Medicines Advances Oncology Platforms Despite Envafolimab Revenue Dip in 2025
8d ago
1244
3D Medicines Sets March 31 Board Meeting to Approve 2025 Results and Mull Dividend
PremiumCompany Announcements
3D Medicines Sets March 31 Board Meeting to Approve 2025 Results and Mull Dividend
21d ago
1244
3D Medicines Moves Envafolimab Toward Full Approval in China
PremiumCompany Announcements
3D Medicines Moves Envafolimab Toward Full Approval in China
2M ago
1244
3D Medicines Appoints Veteran Capital Markets Executive as New CFO
PremiumCompany Announcements
3D Medicines Appoints Veteran Capital Markets Executive as New CFO
3M ago
1244
3D Medicines’ Envafolimab NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
PremiumCompany Announcements3D Medicines’ Envafolimab NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
3M ago
1244
3D Medicines Wins Third Orphan-Drug Designation for Envafolimab in Gastric Cancers
Premium
Company Announcements
3D Medicines Wins Third Orphan-Drug Designation for Envafolimab in Gastric Cancers
4M ago
1244
3D Medicines’ New Cancer Pain Study: Potential Market Impact
Premium
Company Announcements
3D Medicines’ New Cancer Pain Study: Potential Market Impact
5M ago
1244
3D Medicines Reports Strong Progress and Global Expansion in H1 2025
PremiumCompany Announcements
3D Medicines Reports Strong Progress and Global Expansion in H1 2025
7M ago
1244
3D Medicines Administers First Dose of Novel Cancer Drug
PremiumCompany Announcements
3D Medicines Administers First Dose of Novel Cancer Drug
7M ago
1244
3D Medicines Partners with CATUG Biotechnology to Enhance mRNA Therapy Development
PremiumCompany Announcements
3D Medicines Partners with CATUG Biotechnology to Enhance mRNA Therapy Development
8M ago
1244
3D Medicines Inc. Schedules Board Meeting for Interim Results and Dividend Consideration
PremiumCompany Announcements
3D Medicines Inc. Schedules Board Meeting for Interim Results and Dividend Consideration
8M ago
1244
3D Medicines Inc. Announces Withdrawal of Legal Proceedings
PremiumCompany Announcements3D Medicines Inc. Announces Withdrawal of Legal Proceedings
9M ago
1244
3D Medicines Inc. Strengthens Stability with Strategic Agreement
Premium
Company Announcements
3D Medicines Inc. Strengthens Stability with Strategic Agreement
9M ago
1244
3D Medicines, Inc. Enhances Operational Stability Through Strategic Cooperation
Premium
Company Announcements
3D Medicines, Inc. Enhances Operational Stability Through Strategic Cooperation
9M ago
1244
3D Medicines Inc. Announces Successful AGM Resolutions
PremiumCompany Announcements
3D Medicines Inc. Announces Successful AGM Resolutions
9M ago
1244
3D Medicines Inc. Announces Board Composition and Committee Assignments
PremiumCompany Announcements
3D Medicines Inc. Announces Board Composition and Committee Assignments
9M ago
1244
3D Medicines Inc. Announces Board Changes with New Non-Executive Director Appointment
PremiumCompany Announcements
3D Medicines Inc. Announces Board Changes with New Non-Executive Director Appointment
10M ago
1244
3D Medicines Inc. Announces Annual General Meeting to Discuss Key Resolutions
PremiumCompany Announcements
3D Medicines Inc. Announces Annual General Meeting to Discuss Key Resolutions
10M ago
1244
3D Medicines Announces Board Composition and Governance Structure
PremiumCompany Announcements3D Medicines Announces Board Composition and Governance Structure
1y ago
1244
3D Medicines Inc. Forms Nomination Committee for Enhanced Governance
Premium
Company Announcements
3D Medicines Inc. Forms Nomination Committee for Enhanced Governance
1y ago
1244
3D Medicines Inc. Reports 2024 Financial Results Amid Market Challenges
Premium
Company Announcements
3D Medicines Inc. Reports 2024 Financial Results Amid Market Challenges
1y ago
1244

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >